לפניכם הרצאות המפגש שהתקיים ב-20.6.2016 ב-RiverSide תל אביב
Non-Invasive and Comprehensive Identification of
NCCN Genomic Targets for Matched Therapy with
Cell-Free DNA
Rick Lanman, MD,
Chief Medical Officer, Guardant360
Lung Cancer Liquid Tumor Board
Double Primary Tumors: an additional value of a liquid biopsy
Elizabeth Dudnik, MD
Davidoff Medical Center
Lung Cancer Liquid Tumor Board
Panel
Rick Lanman, MD, Nir Peled, MD, Hovav Nechushtan, MD, PhD, Elizabeth Dudnik, MD,Deborah T. Blumenthal, MD, , Dov Hershkovitz, MD, PhD
Breast Cancer Liquid Tumor Board
Panel
Rick Lanman, MD, Tamar Yablonski-Peretz, MD, Noa Efrat Ben-Baruch, MD, Shulamith Rizel, MD,
GI Cancer Liquid Tumor Board
Case presentation: Cholangiocarcinoma
Irit Ben Aharon, MD, PhD,
Davidoff Medical Center